Chronic Kidney Disease involves the participation of several inflammatory events that culminate in renal interstitial fibrosis, even when the process has in the glomeruli. Preventing the progression of chronic nephropathies is one of the greatest challenges faced by nephrologists. Proteinuria correlates with the rate of progression, particularly in glomerulopathies, as well as with the extent of glomerular injury and interstitial inflammation. According to one of the hypotheses proposed to explain this correlation, excessive passage of proteins through the glomerular barrier exerts a toxic effect on proximal tubular cells, which in turn synthesize large amounts of inflammatory mediators. However, the mechanisms that lead to this purported effect are unclear. The aim of the present project is to verify the hypothesis that this intense reabsorption and hydrolysis of proteins leads to stimulation of innate immunity in proximal cells, thus activating inflammatory cascades. To accomplish this goal, we will examine, at various stages of evolution, the adriamycin nephropathy model, which is characterized by massive proteinuria and, in the long run, glomerular and interstitial injury. As an in vitro counterpart, a preparation of cultured cells will be exposed to different concentrations of albumin. If this hypothesis is correct, activation of innate immunity will occur upon exposure to high protein concentrations, thus contributing to clarify the mechanisms of interstitial injury in proteinuric states and helping to define potential new therapeutic targets.
News published in Agência FAPESP Newsletter about the scholarship: